InFLAMES Flagship
Contact Details
Persons
Publications
- Sytokiinireseptorit (2024)
- Sytokiinit (2024)
- Taipuu vaan ei taitu - koronapandemiasta Suomen kriisinkestävyyden vahvistamiseen (2021)
- Targeted serum proteomics of longitudinal samples from newly diagnosed youth with type 1 diabetes affirms markers of disease (2025)
- Targeted serum proteomics of longitudinal samples from newly diagnosed youth with type 1 diabetes distinguishes markers of disease and C-peptide trajectory (2023)
- Targeting sex steroid biosynthesis for breast and prostate cancer therapy (2023)
- Target-specific compound selectivity for multi-target drug discovery and repurposing (2022)
- Targetting folate receptor-β expressing macrophages by 18F-labelled folate PET radiotracer in rat model of myocardial infarction (2022)
- Tau-targeting antisense oligonucleotide MAPTRx in mild Alzheimer’s disease: a phase 1b, randomized, placebo-controlled trial (2024)
- T cell immunity following COVID-19 vaccination in adult patients with primary antibody deficiency - a 22-month follow-up (2023)